Company Filing History:
3 out of 216 
1 out of 2,405 
Years Active: 2007-2013
Title: P Douglas Boatman: Innovator in Pharmacological Compounds
Introduction
P Douglas Boatman is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmacology, particularly through his innovative compounds that target various health disorders. With a total of 3 patents, Boatman has established himself as a key figure in the development of therapeutic agents.
Latest Patents
Boatman's latest patents include groundbreaking work on 3H-imidazo[4,5-b]pyridin-5-ol derivatives. These compounds exhibit useful pharmacological properties, acting as agonists of the GPR81 receptor. They are designed to treat a range of disorders, including dyslipidemia, atherosclerosis, and type 2 diabetes. Another significant patent involves fused pyrazole derivatives, which also serve as agonists for the RUP25 receptor. These compounds are aimed at treating metabolic-related disorders and can be used in combination with other active agents.
Career Highlights
Throughout his career, Boatman has worked with prominent companies in the pharmaceutical industry, including Arena Pharmaceuticals, Inc. and Merck Sharp & Dohme Corp. His work has focused on developing innovative solutions to complex health issues, showcasing his expertise in pharmacological research.
Collaborations
Boatman has collaborated with esteemed colleagues such as Thomas O. Schrader and Philip J. Skinner. These partnerships have further enhanced his research and development efforts in the pharmaceutical field.
Conclusion
P Douglas Boatman is a distinguished inventor whose work in pharmacological compounds has the potential to impact numerous health conditions. His innovative patents and collaborations reflect his commitment to advancing medical science.